Page last updated: 2024-11-06

prinomide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

prinomide: RN given from Toxline; RN not in Chemline 7/87; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID60352
CHEMBL ID2111033
CHEBI ID8415
SCHEMBL ID5083349
SCHEMBL ID22612706
MeSH IDM0150071

Synonyms (23)

Synonym
prinomide [inn]
AC1Q3YWG ,
prinomide
77639-66-8
2-cyano-3-(1-methylpyrrol-2-yl)-3-oxo-n-phenylpropanamide
AC1L1T2N ,
unii-6nhc09l02i
6nhc09l02i ,
prinomide [who-dd]
1-methyl-beta-oxo-alpha-phenylcarbamoyl-2-pyrrolpropionitrile
1-methyl-beta-oxo-alpha-phenylcarbamoyl-2-pyrrol-propionitrile
KBQUAIAGRLAZGP-UHFFFAOYSA-N
1-methyl-beta-oxo-alpha-(phenylcarbamoyl)-2-pyrrolepropionitrile
SCHEMBL5083349
CHEBI:8415 ,
CHEMBL2111033
2-cyano-3-(1-methylpyrrol-2-yl)-3-oxo-n-phenyl-propanamide
2-cyano-3-(1-methyl-1h-pyrrol-2-yl)-3-oxo-n-phenylpropanamide
Q27108072
alpha-cyano-1-methyl-beta-oxo-n-phenyl-1h-pyrrole-2-propanamide
SCHEMBL22612706
-cyano-1-methyl--oxo-n-phenyl-1h-pyrrole-2-propanamide
DTXSID40868449

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic behavior of prinomide and its primary plasma metabolite displayed nonlinear characteristics, while those of free prinomide and its metabolite were dose proportional."( Prinomide tromethamine pharmacokinetics: mutually dependent saturable and competitive protein binding between prinomide and its own metabolite.
Egger, H; Honc, F; Iannucci, R; Kachmar, D; Kochak, GM; Pai, S; Perrino, P, 1993
)
2.01

Dosage Studied

ExcerptRelevanceReference
"The disposition and metabolism of prinomide, the 1:1 triethanolamine salt of 1-methyl-beta-oxo-alpha-(phenylcarbamoyl)-2-pyrrolepropionitrile (CGS 10787B), have been investigated in a number of animal species after single and multiple oral dosing with 14C-labeled and unlabeled drug."( Disposition and metabolism of prinomide in laboratory animals.
Egger, H; Itterly, W; John, V; Kapoor, A; Rodebaugh, R; Shimanskas, C; Stancato, F,
)
0.7
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
anilideAny aromatic amide obtained by acylation of aniline.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]